Intervention Review

Prostaglandin E1 for treatment of erectile dysfunction

  1. Riccardo Urciuoli1,*,
  2. Teresa Anna Cantisani1,
  3. Marzia Carlini2,
  4. Marta Giuglietti1,
  5. Fabio Massimo Botti3

Editorial Group: Cochrane Multiple Sclerosis Group

Published Online: 19 APR 2004

Assessed as up-to-date: 28 JUN 2003

DOI: 10.1002/14651858.CD001784.pub2

How to Cite

Urciuoli R, Cantisani TA, Carlini M, Giuglietti M, Botti FM. Prostaglandin E1 for treatment of erectile dysfunction. Cochrane Database of Systematic Reviews 2004, Issue 2. Art. No.: CD001784. DOI: 10.1002/14651858.CD001784.pub2.

Author Information

  1. 1

    Azienda Ospedaliera Perugia, Neurofisiopatologia, Perugia, UMBRIA, Italy

  2. 2

    ASL3 Regione Umbria, Neurofisiopatologia, SPOLETO, Italy

  3. 3

    ASL3 Regione Umbria, Neuroriabilitazione, TREVI, UMBRIA, Italy

*Riccardo Urciuoli, Neurofisiopatologia, Azienda Ospedaliera Perugia, San Andrea Delle Fratte, San Sisto, Perugia, UMBRIA, 06156, Italy. r.urciuoli@infinito.it.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 19 APR 2004

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Dragan Ilic, Ben Hindson, Gillian Duchesne, Jeremy L Millar, A randomised, double-blind, placebo-controlled trial of nightly sildenafil citrate to preserve erectile function after radiation treatment for prostate cancer, Journal of Medical Imaging and Radiation Oncology, 2013, 57, 1
  2. 2
    Lasantha S. Malavige, Jonathan C. Levy, Erectile Dysfunction in Diabetes Mellitus, The Journal of Sexual Medicine, 2009, 6, 5
  3. 3
    Carol C. Pilbeam, Shilpa Choudhary, Katherine Blackwell, Lawrence G. Raisz, Principles of Bone Biology, 2008,

    CrossRef

  4. 4
    Virginia Guillén, José-Ramón Rueda, Javier Ballesteros, Marta López de Argumedo, Apomorphine for the treatment of erectile dysfunction, The Cochrane Library,